Search

I joined the CTU in September 2018. I work primarily on the ERIC-PPCI, safetxt and Tight K trials.

Around the world, one woman dies every five minutes from excessive bleeding after giving birth, a medical complication known as postpartum haemorrhage. The majority of these women live in low- and middle-income countries where access to life-saving emergency healthcare is often limited.  The...

Trauma-INTACT is a prospective, open-label, multicentre, pharmacokinetic study. Objective:  To assess the population pharmacokinetics of intramuscular TXA in trauma patients. Background:  The anti-fibrinolytic TXA has been licensed for over 30 years for use in the prevention and...

I started working at LSHTM as a Trials Assistant in April 2019 and I am currently involved in two trials: safetxt and REVIVED. Before joining the Clinical Trials Unit, I graduated from Brunel University with a BSc (Hons) in Biomedical Science and went on to work at the University of London...

Postpartum haemorrhage (PPH) is responsible for about 100,000 maternal deaths every year, almost all of which occur in low and middle income countries. When given within three hours of birth, tranexamic acid reduces deaths due to bleeding in women with PPH by almost one third. However, for many...